Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 | 
| NetGPI | no | yes: 0, no: 8 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 | 
| GO:0005930 | axoneme | 2 | 1 | 
| GO:0110165 | cellular anatomical entity | 1 | 1 | 
Related structures:
AlphaFold database: A4IBL3
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.689 | 
| CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.579 | 
| CLV_PCSK_PC1ET2_1 | 10 | 12 | PF00082 | 0.599 | 
| CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.586 | 
| CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.596 | 
| DOC_PP2B_LxvP_1 | 20 | 23 | PF13499 | 0.608 | 
| DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.510 | 
| DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.681 | 
| DOC_USP7_UBL2_3 | 10 | 14 | PF12436 | 0.659 | 
| DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.463 | 
| LIG_14-3-3_CanoR_1 | 67 | 76 | PF00244 | 0.575 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.794 | 
| LIG_FHA_1 | 56 | 62 | PF00498 | 0.539 | 
| LIG_FHA_1 | 88 | 94 | PF00498 | 0.477 | 
| LIG_FHA_2 | 28 | 34 | PF00498 | 0.468 | 
| LIG_FHA_2 | 58 | 64 | PF00498 | 0.535 | 
| LIG_FHA_2 | 87 | 93 | PF00498 | 0.509 | 
| LIG_LIR_LC3C_4 | 44 | 49 | PF02991 | 0.535 | 
| LIG_LIR_Nem_3 | 107 | 113 | PF02991 | 0.469 | 
| LIG_MYND_1 | 18 | 22 | PF01753 | 0.529 | 
| LIG_RPA_C_Fungi | 153 | 165 | PF08784 | 0.419 | 
| LIG_SH2_CRK | 85 | 89 | PF00017 | 0.500 | 
| LIG_SH2_NCK_1 | 85 | 89 | PF00017 | 0.500 | 
| LIG_SH2_SRC | 108 | 111 | PF00017 | 0.476 | 
| LIG_SH3_1 | 15 | 21 | PF00018 | 0.633 | 
| LIG_SH3_3 | 15 | 21 | PF00018 | 0.611 | 
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.427 | 
| LIG_SUMO_SIM_anti_2 | 44 | 51 | PF11976 | 0.512 | 
| LIG_SUMO_SIM_par_1 | 44 | 51 | PF11976 | 0.437 | 
| LIG_WW_2 | 18 | 21 | PF00397 | 0.534 | 
| MOD_CK1_1 | 4 | 10 | PF00069 | 0.687 | 
| MOD_CK1_1 | 70 | 76 | PF00069 | 0.566 | 
| MOD_CK2_1 | 57 | 63 | PF00069 | 0.534 | 
| MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.540 | 
| MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.710 | 
| MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.556 | 
| MOD_GSK3_1 | 1 | 8 | PF00069 | 0.695 | 
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.498 | 
| MOD_GSK3_1 | 70 | 77 | PF00069 | 0.567 | 
| MOD_GSK3_1 | 93 | 100 | PF00069 | 0.528 | 
| MOD_N-GLC_1 | 68 | 73 | PF02516 | 0.502 | 
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.737 | 
| MOD_NEK2_1 | 104 | 109 | PF00069 | 0.375 | 
| MOD_NEK2_1 | 131 | 136 | PF00069 | 0.513 | 
| MOD_NEK2_1 | 68 | 73 | PF00069 | 0.509 | 
| MOD_NEK2_1 | 97 | 102 | PF00069 | 0.461 | 
| MOD_PIKK_1 | 131 | 137 | PF00454 | 0.521 | 
| MOD_PKA_2 | 4 | 10 | PF00069 | 0.646 | 
| MOD_Plk_4 | 57 | 63 | PF00069 | 0.470 | 
| MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.468 | 
| TRG_DiLeu_BaEn_1 | 123 | 128 | PF01217 | 0.482 | 
| TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.475 | 
| TRG_NLS_MonoExtC_3 | 9 | 14 | PF00514 | 0.723 | 
| TRG_NLS_MonoExtN_4 | 10 | 17 | PF00514 | 0.661 | 
| TRG_Pf-PMV_PEXEL_1 | 29 | 33 | PF00026 | 0.405 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1PCS8 | Leptomonas seymouri | 54% | 97% | 
| A0A1X0P5D6 | Trypanosomatidae | 42% | 100% | 
| A0A3S7X9I9 | Leishmania donovani | 99% | 100% | 
| A4HMY9 | Leishmania braziliensis | 79% | 100% | 
| C9ZZ27 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 99% | 
| E9AFE6 | Leishmania major | 95% | 100% | 
| E9B6K1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |